Franco O. Ranelletti

7.2k total citations
128 papers, 6.0k citations indexed

About

Franco O. Ranelletti is a scholar working on Molecular Biology, Genetics and Oncology. According to data from OpenAlex, Franco O. Ranelletti has authored 128 papers receiving a total of 6.0k indexed citations (citations by other indexed papers that have themselves been cited), including 50 papers in Molecular Biology, 39 papers in Genetics and 29 papers in Oncology. Recurrent topics in Franco O. Ranelletti's work include Estrogen and related hormone effects (37 papers), Inflammatory mediators and NSAID effects (27 papers) and Cancer, Lipids, and Metabolism (18 papers). Franco O. Ranelletti is often cited by papers focused on Estrogen and related hormone effects (37 papers), Inflammatory mediators and NSAID effects (27 papers) and Cancer, Lipids, and Metabolism (18 papers). Franco O. Ranelletti collaborates with scholars based in Italy, United States and Japan. Franco O. Ranelletti's co-authors include Giovanni Scambia, Mauro Piantelli, Gabriella Ferrandina, Nicola Maggiano, Libero Lauriola, Paola Palozza, Gabriella Calviello, Simona Serini, N Maggiano and Enrica Martinelli and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Clinical Oncology and Blood.

In The Last Decade

Franco O. Ranelletti

127 papers receiving 5.8k citations

Peers

Franco O. Ranelletti
Margaret M. Manson United Kingdom
Chapla Agarwal United States
Clinton J. Grubbs United States
Nanjoo Suh United States
Vaqar M. Adhami United States
Richard C. Moon United States
Franco O. Ranelletti
Citations per year, relative to Franco O. Ranelletti Franco O. Ranelletti (= 1×) peers Hideki Mori

Countries citing papers authored by Franco O. Ranelletti

Since Specialization
Citations

This map shows the geographic impact of Franco O. Ranelletti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco O. Ranelletti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco O. Ranelletti more than expected).

Fields of papers citing papers by Franco O. Ranelletti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco O. Ranelletti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco O. Ranelletti. The network helps show where Franco O. Ranelletti may publish in the future.

Co-authorship network of co-authors of Franco O. Ranelletti

This figure shows the co-authorship network connecting the top 25 collaborators of Franco O. Ranelletti. A scholar is included among the top collaborators of Franco O. Ranelletti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco O. Ranelletti. Franco O. Ranelletti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ranelletti, Franco O., Paolo Felaco, Luca Gattinoni, et al.. (2023). Independent Prognostic and Predictive Role of Interstitial Macrophages in Kidney Biopsies of IgA Nephropathy Patients. Journal of Personalized Medicine. 13(6). 935–935.
2.
Amadio, Patrizia, Bianca Rocca, Maurizio Pesce, et al.. (2015). Abnormal megakaryopoiesis and platelet function in cyclooxygenase-2-deficient mice. Thrombosis and Haemostasis. 114(12). 1218–1229. 11 indexed citations
3.
Serini, Simona, Valentina Donato, Elisabetta Piccioni, et al.. (2010). Docosahexaenoic acid reverts resistance to UV-induced apoptosis in human keratinocytes: involvement of COX-2 and HuR. The Journal of Nutritional Biochemistry. 22(9). 874–885. 29 indexed citations
4.
Palozza, Paola, Rossella Simone, Assunta Catalano, et al.. (2010). Lycopene prevention of oxysterol-induced proinflammatory cytokine cascade in human macrophages: inhibition of NF-κB nuclear binding and increase in PPARγ expression. The Journal of Nutritional Biochemistry. 22(3). 259–268. 93 indexed citations
5.
Palozza, Paola, Rosanna Sestito, Nevio Picci, et al.. (2008). The sensitivity to  -carotene growth-inhibitory and proapoptotic effects is regulated by caveolin-1 expression in human colon and prostate cancer cells. Carcinogenesis. 29(11). 2153–2161. 30 indexed citations
7.
Ferrandina, Gabriella, Franco O. Ranelletti, Enrica Martinelli, et al.. (2006). Cyclo-oxygenase-2 (Cox-2) expression and resistance to platinum versus platinum/paclitaxel containing chemotherapy in advanced ovarian cancer. BMC Cancer. 6(1). 182–182. 20 indexed citations
8.
Ferrandina, Gabriella, Francesco Legge, Elisa Martina Martinelli, et al.. (2005). Survivin expression in ovarian cancer and its correlation with clinico-pathological, surgical and apoptosis-related parameters. British Journal of Cancer. 92(2). 271–277. 73 indexed citations
9.
Rocca, Bianca, Roberta Morosetti, Aı̈da Habib, et al.. (2004). Cyclooxygenase-1, but not -2, is upregulated in NB4 leukemic cells and human primary promyelocytic blasts during differentiation. Leukemia. 18(8). 1373–1379. 21 indexed citations
10.
Ferlini, Cristiano, Giuseppina Raspaglio, Simona Mozzetti, et al.. (2003). Bcl-2 Down-Regulation Is a Novel Mechanism of Paclitaxel Resistance. Molecular Pharmacology. 64(1). 51–58. 122 indexed citations
11.
Ferrandina, Gabriella, Franco O. Ranelletti, Vanda Salutari, et al.. (2003). Expression of cyclooxygenase-2 (COX-2) in non-neoplastic and neoplastic vulvar epithelial lesions. Gynecologic Oncology. 92(2). 537–544. 17 indexed citations
12.
Ferrandina, Gabriella, Franco O. Ranelletti, Libero Lauriola, et al.. (2002). Cyclooxygenase-2 (COX-2), Epidermal Growth Factor Receptor (EGFR), and Her-2/neu Expression in Ovarian Cancer. Gynecologic Oncology. 85(2). 305–310. 85 indexed citations
13.
Brunetti, Mauro, et al.. (2002). Synergistic inhibitory activities of interleukin-10 and dexamethasone on human CD4+ T cells1. Transplantation. 74(8). 1152–1158. 4 indexed citations
14.
Rossi, Cosmo, Andreina Poggi, Franco O. Ranelletti, et al.. (2000). Flavonoids apigenin and quercetin inhibit melanoma growth and metastatic potential. International Journal of Cancer. 87(4). 595–600. 379 indexed citations
15.
Ferrandina, Gabriella, Franco O. Ranelletti, Giovanni Scambia, et al.. (1995). Interaction of tamoxifen with cytosolic and nuclear Type II estrogen binding sites (Type II EBS). Cancer Letters. 96(1). 123–131. 2 indexed citations
16.
Piantelli, Mauro, A. Rinelli, Nicola Maggiano, et al.. (1993). Type II estrogen binding sites and antiproliferative activity of quercetin in human meningiomas. Cancer. 71(1). 193–198. 35 indexed citations
17.
Teofili, Luciana, Luca Pierelli, Giuseppe Leone, et al.. (1992). The combination of quercetin and cytosine arabinoside synergistically inhibits leukemic cell growth. Leukemia Research. 16(5). 497–503. 43 indexed citations
18.
Maggiano, N, Luigi Maria Larocca, Mauro Piantelli, et al.. (1991). Detection of mRNA and hnRNA using a digoxigenin labelled cDNA probe byin situ hybridization on frozen tissue sections. The Histochemical Journal. 23(2). 69–74. 10 indexed citations
19.
Ranelletti, Franco O., Marco Carmignani, Stefano Iacobelli, & Pietro Tonali. (1978). Glucocorticoid-binding components in human thymus hyperplasia.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(3). 516–20. 10 indexed citations
20.
Iacobelli, Stefano, Franco O. Ranelletti, Paola Longo, Riccardo Riccardi, & Renato Mastrangelo. (1978). Discrepancies between in vivo and in vitro effects of glucorticoids in myelomonocytic leukemic cells with steroid receptors.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 38(11 Pt 2). 4257–62. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026